Results
SECONDARY, CONTRACTION, INCONTINENCE
Figure 
 The flow of participants through the randomized clinical trialOf the eighteen individuals randomly assigned to the treatment group, two did not complete the trial: one was lost to follow-up, and one withdrew from participation because of lack of time. Of the eighteen women randomized to the control group, two did not complete the trial: one was lost to follow-up, and one withdrew informed consent before taking any supplement. In total, thirty-six women completed the trial: sixteen in the control group and sixteen in the treatment group.There were no demographic differences between the two groups (Table 
Primary and secondary outcomes at baseline and completion of the study. Between-group analysis was performedUrogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Patient Global Impression of Severity and Improvement question (PGI-S and PGI-I)
Fifty-two VTI parameters for women in the control group at baseline and completion of trial
Fifty-two VTI parameters for women in the treatment group at baseline and completion of trialWithin-group analysis showed that UDI-6 and IIQ-7 scores improved significantly from baseline to six weeks in the treatment group but not in the control group [UDI-6 score (mean ± SD) 45 ± 21 vs. 29 ± 21, P = 0.02 (treatment group), 43 ± 18 vs. 33 ± 26, P = 0.22 (control group)] [IIQ-7 score before (mean ± SD) 50 ± 30 vs. 30 ± 21, P = 0.01 (treatment group) 48 ± 23 vs.40 ± 28, P = 0.36 (control group)] (Table 
Primary and secondary outcomes at baseline and the completion of study. Within-group analysis was performedUrogenital Distress Inventory (UDI-6), Incontinence Impact Questionnaire (IIQ-7), Patient Global Impression of Severity (PGI-S)Vaginal Tactile Imaging revealed that in the control group, only three VTI parameters improved (VTI #6, 10, 49), while in the treatment group, eleven parameters were better (VTI #1,5, 19, 37, 40–46) (Tables 
Boxplots for components of the Biomechanical Integrity ScoreAt baseline and at the completion of the study: Elasticity (P = 0.035), Contraction, Support, Relaxation (P = 0.0004), and Mobility. BI-score was significantly improved (P = 0.0012)
Biomechanical Integrity Score (BI-score) in Control GroupBI-score is measured by Vaginal Tactile Imager at baseline and the completion of the study
Biomechanical Integrity Score (BI-score) in Treatment GroupBI-score is measured by Vaginal Tactile Imager at baseline and the completion of the study